Kyoung Eun Baek

Title: Kyoung Eun Baek: Innovator in Monoclonal Antibody Research

Introduction

Kyoung Eun Baek is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on cancer-related factors, which has the potential to impact clinical research and treatment.

Latest Patents

Kyoung Eun Baek holds 1 patent related to a monoclonal antibody specific for N-myc downstream regulated gene 2 (NDRG 2) protein. This invention includes a cell line producing the monoclonal antibody, a method for measuring the quantity and quality of NDRG 2 protein, and a protein chip utilizing this technology. The NDRG 2 protein is specifically expressed in dendritic cells differentiated from human peripheral blood monocytes. This innovation can aid in elucidating the characteristics of dendritic cells and facilitate research on NDRG 2, potentially leading to advancements in the investigation and treatment of intractable diseases and cancers.

Career Highlights

Kyoung Eun Baek is affiliated with the Korea Research Institute of Bioscience and Biotechnology. His work at this esteemed institution has allowed him to focus on groundbreaking research in the field of bioscience. His contributions have been recognized within the scientific community, showcasing his dedication to advancing medical research.

Collaborations

Kyoung Eun Baek has collaborated with notable colleagues, including Eun Young Song and Jae Wha Kim. These partnerships have fostered a collaborative environment that enhances the research output and innovation in their respective fields.

Conclusion

Kyoung Eun Baek is a distinguished inventor whose work in monoclonal antibody research holds promise for significant advancements in cancer treatment and understanding. His contributions to biotechnology continue to pave the way for future innovations in the medical field.